AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
#64 – Putting the Fun in Fungi: A Fun-guide to New Antifungals
Breakpoints
Ibrexifunder Is FDA Approved to Treat Volovaginal Candidasis
Ibrexifunder is FDA approved to the treatment of volovaginal candidiasis, specifically in adult and post-menar goal of emails. It inhibits one, three beta D glue pan synthase which sounds an awful lot like cannons but it does interact with a unique binding site. There are no adjustments for renal or hepatic dysfunction, but there are significant drug interactions.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode